Clinical Trials Directory

Trials / Unknown

UnknownNCT04258982

The Copmparison of Accuracy of PtcCO2 and in PetCO2 in COPD Patients With NIV Treatment

Status
Unknown
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
Zhenfeng He · Academic / Other
Sex
All
Age
20 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The chronic obstructive pulmonary disease (COPD) patients with type II respiratory failure always needs PaCO2 test to monitor the changes of disease. Method used mostly nowadays to detect PaCO2 is arterial puncture which is accurate but is invasive, painful and non-dynamic. Noninvasive measurement methods includes end-tidal CO2 (PetCO2), transcutaneous CO2 (PtcCO2) which can monitor the PaCO2 dynamically and noninvasively, but their accuracy is in controversy. Common PetCO2 is especially inaccurate in COPD patients while our team find that the accuracy can be improved by prolong expiration method (PetCO2 (P)).So the investigators want to compare the accuracy of PtcCO2 and PetCO2(P) in AECOPD patients during noninvasive ventilation(NIV).

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2019-02-08
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2020-02-06
Last updated
2021-02-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04258982. Inclusion in this directory is not an endorsement.

The Copmparison of Accuracy of PtcCO2 and in PetCO2 in COPD Patients With NIV Treatment (NCT04258982) · Clinical Trials Directory